Ottawa, November 21, 2018 The following statement can be attributed to Innovative Medicines Canada President, Pamela Fralick. “As a driver of innovation, the innovative pharmaceutical industry welcomes the targeted measures […]
IMC welcomes ISED roundtable recommendations […]
Ottawa, July 3, 2018 – Innovative Medicines Canada congratulates the new Ontario Minister of Health and Long-Term Care, Christine Elliott, on moving decisively to revamp OHIP+. “It’s a win-win for […]
Ottawa, April 19, 2018 – The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada agrees with the House of Commons Standing Committee on […]
Ottawa, April 12, 2018 – The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “All members of Innovative Medicines Canada are bound by the association’s Code of […]
Montreal, March 27, 2018 – In response to the budget tabled by Quebec Finance Minister Carlos Leitão, Innovative Medicines Canada welcomes investment to support the innovative life sciences sector in […]
Ottawa, February 27, 2018 – Innovative Medicines Canada and its member companies welcome the appointment of Dr. Eric Hoskins as the Chair of the Advisory Council on the Implementation of […]
Ottawa, February 8, 2018 – We are at a pivotal moment in the evolution of life sciences. For the first time in human history the ability to cure cancer is within […]
With regards to today’s publication of proposed amendments to the Patented Medicines Regulations, Pamela Fralick, President, Innovative Medicines Canada issued the following statement: “Innovative Medicines Canada is currently reviewing the […]
Ottawa, November 27, 2017 – In response to the launch of the Ontario Progressive Conservative Party election platform, Innovative Medicines Canada welcomes the policy commitments aimed at improving access to innovative […]
